This webinar will summarize the Sunshine Act or Open Payments Program requirements and provide practical solutions to the most common situations that are prevalent and necessary between sponsors and investigators.
The Sunshine Act or Open Payments Program requires manufacturers of drugs, medical devices, and biologics that participate in U.S. federal health care programs to report certain clinical investigator payments and items of value given to physicians and teaching hospitals. This Act was part of a healthcare reform bill adopted in March 2010. It came about due to requests for increased transparency about the financial relationships between physicians and the industry.
WHY SHOULD YOU ATTEND?
The Sunshine Act exposes the physicians and sponsors to new clinical trial reporting requirements and detail non-compliance which would lead to hefty fines. Templates for reporting format, exemptions to reporting requirements, and timelines for compliance and enforcement will be discussed.
AREA COVERED
Life science companies face the challenge of implementing the detailed reporting required by the Act as healthcare providers determine how to use their own data to anticipate public reporting of payments by life science companies to physicians and teaching hospitals.
This webinar will examine the implications of the Sunshine Act for healthcare providers and life science companies and discuss practical steps they can take to implement the Act and prepare for transparency.
- Purpose of the Sunshine Act
- Who is required to report under the Sunshine Act?
- What is reported?
- Exclusions
- Tracking
- Penalties
- Useful links
WHO WILL BENEFIT?
- Manufacturers of FDA-regulated products: Drug, Medical Device, and Biotech Companies
- Clinical Trial Professionals such as Project Managers, CRAs, Medical Writers
- Senior Management for Companies developing new products for the US market
- Regulatory Affairs Professionals
- People investing in FDA-regulated products intended for the US market
The Sunshine Act exposes the physicians and sponsors to new clinical trial reporting requirements and detail non-compliance which would lead to hefty fines. Templates for reporting format, exemptions to reporting requirements, and timelines for compliance and enforcement will be discussed.
Life science companies face the challenge of implementing the detailed reporting required by the Act as healthcare providers determine how to use their own data to anticipate public reporting of payments by life science companies to physicians and teaching hospitals.
This webinar will examine the implications of the Sunshine Act for healthcare providers and life science companies and discuss practical steps they can take to implement the Act and prepare for transparency.
- Purpose of the Sunshine Act
- Who is required to report under the Sunshine Act?
- What is reported?
- Exclusions
- Tracking
- Penalties
- Useful links
- Manufacturers of FDA-regulated products: Drug, Medical Device, and Biotech Companies
- Clinical Trial Professionals such as Project Managers, CRAs, Medical Writers
- Senior Management for Companies developing new products for the US market
- Regulatory Affairs Professionals
- People investing in FDA-regulated products intended for the US market
Speaker Profile

Danielle DeLucy, MS, is owner of ASA Training and Consulting, LLC which provides Pharmaceutical and Biologics based companies with training and quality systems assistance in order to meet Regulatory compliance. Prior to this role, Danielle has been in the industry for 15 years serving in numerous Quality Management Roles, such as the Director of Product Quality, the oversight of Sterility Assurance practices and provided QA oversight of numerous filling and packaging operations. Danielle began her QA career as a Quality Control Pharmaceutical Microbiologist at a contract laboratory where she performed various tests for their clients. In the years after, she …
Upcoming Webinars

2025 Handbook Overhaul: Navigating Critical Updates! Federa…


Dealing With Difficult People In Life & Work

Harassment, Bullying, Gossip, Confrontational and Disruptiv…

Copilot and HR: An Introduction for HR Professionals

Beat Workplace Burnout: 10 Proven Techniques to Manage Your…

Workplace Investigations Uncovered: Best Practices and Stra…

Employers Should Prepare for Immigration Raids in 2025! Thi…

Managing Toxic Employees: Strategies For Leaders To Effecti…


Keys to Captivating an Audience: Informing and Inspiring t…

Do's and Don'ts of Documenting Employee Behaviour, Performa…

Understanding Artificial Intelligence (AI) & using Chat GPT

Transform Data into Insights: A Beginners Guide to Excel Pi…

Empowering Conflict Resolution: Letting Go to Gain Control


Outlook - Master your Mailbox - Inbox Hero Inbox Zero

Bootcamp for New Managers and Supervisors: Develop These Es…

Project Management for administrative professionals

Negotiating Skills For Professional Results - Winning Strat…

How to Write Effective Audit Observations: The Principles f…


How to Use ChatGPT to Write Employee Evaluations


Power BI - Getting Started Building Reports and Dashboards

3-Hour Virtual Boot Camp on Easier Excel Automation with VB…


Onboarding is NOT Orientation - How to Improve the New Empl…

How to Conduct Exit Interviews - Implementing and Enhancing…

Onboarding Best Practices for 2025: Proven Strategies to Po…

Form W-9 Compliance: TIN Verification, B Notices, and Avoid…

The Five Cs Of Commercial Credit: The Basic Elements Of Cre…

2025 EEOC & Employers: Investigating Claims of Harassment …

2-Hour Virtual Seminar on How to Conduct an Internal Harass…